MyMedR

Displaying all 2 publications

Abstract:

Sort:

Fulltext Retrospective Analysis of Cancer Care Performance and Survival Outcome for Nasopharyngeal Carcinoma at a leading Cancer Treatment Centre in Malaysia 2008-2012

Abdullah MM, Foo YC, Yap BK, Lee CML, Hoo LP, Lim TO

Asian Pac J Cancer Prev, 2019 06 01;20(6):1701-1708.
PMID: 31244290 DOI: 10.31557/APJCP.2019.20.6.1701

Objective: This report focuses on a private medical centre cancer care performance as measured by patient survival
outcome for up to 5 years. Methods: All patients with nasopharyngeal cancer treated at SJMC between 2008 and 2012
were enrolled for this observational cohort study. Mortality outcome was ascertained through record linkage with
national death register, linkage with hospital registration system and finally through direct contact by phone. Result:
266 patients treated between 2008 and 2012 were included for survival analysis. 31% of patients were diagnosed with
Early NPC Cancer (Stage I or II), another 44% with Locally Advanced Cancer (Stage III) and 25% with late stage IV
metastatic cancer. 2%, 27% and 67% had WHO Class I, II and III NPC respectively. The overall survival at 5 years
was 100% for patients with Stage I disease, 91% for Stage II disease, 72% for Stage III disease, and decreasing to
44% for Stage IV disease. Overall survival at 5 years for all stages was 73%. Conclusion: SJMC is among the first
hospitals in Malaysia to embark on routine measurement of the performance of its cancer care services and its results
are comparable to any leading centers in developed countries.
Breast Cancer Survival at a Leading Cancer Centre in Malaysia

Abdullah MM, Mohamed AK, Foo YC, Lee CM, Chua CT, Wu CH, et al.

Asian Pac J Cancer Prev, 2015;16(18):8513-7.
PMID: 26745110

BACKGROUND: GLOBOCAN12 recently reported high cancer mortality in Malaysia suggesting its cancer health services are under-performing. Cancer survival is a key index of the overall effectiveness of health services in the management of patients. This report focuses on Subang Jaya Medical Centre (SJMC) care performance as measured by patient survival outcome for up to 5 years.
MATERIALS AND METHODS: All women with breast cancer treated at SJMC between 2008 and 2012 were enrolled for this observational cohort study. Mortality outcome was ascertained through record linkage with national death register, linkage with hospital registration system and finally through direct contact by phone or home visits.
RESULTS: A total of 675 patients treated between 2008 and 2012 were included in the present survival analysis, 65% with early breast cancer, 20% with locally advanced breast cancer (LABC) and 4% with metastatic breast cancer (MBC). The overall relative survival (RS) at 5 years was 88%. RS for stage I was 100% and for stage II, III and IV disease was 95%, 69% and 36% respectively.
CONCLUSIONS: SJMC is among the first hospitals in Malaysia to embark on routine measurement of the performance of its cancer care services and its results are comparable to any leading centers in developed countries.

Filters

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links